![James Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kelly
Finansdirektör/CFO på
NOVAVAX, INC.
Förmögenhet: 1 M $ per 2026-08-31
Profil
James Patrick Kelly is Chief Financial Officer, Treasurer & Executive VP at Novavax, Inc. since 2021.
Mr. Kelly is a Member of The Association of Bioscience Financial Officers.
Formerly, Mr. Kelly was Chief Financial Officer, Treasurer & Executive VP at Vanda Pharmaceuticals, Inc. from 2018 to 2020.
Mr. Kelly was Chief Financial Officer & Executive Vice President at Supernus Pharmaceuticals, Inc. from 2020 to 2021.
Mr. Kelly was Vice President & Controller at MedImmune LLC from 2006 to 2010.
Mr. Kelly was Director-Planning & Operations at Biogen, Inc. from 2000 to 2005.
Mr. Kelly was Principal at Aetna, Inc. from 1997 to 2000.
Mr. Kelly earned an MBA from Cornell University in 1997.
Mr. Kelly earned an undergraduate degree from the University of Vermont in 1988.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NOVAVAX, INC. 0,08 % | 2026-04-23 | 130 599 ( 0,08 % ) | 1 M $ | 2026-08-31 |
Aktiva positioner av James Kelly
| Företag | Position | Start |
|---|---|---|
| NOVAVAX, INC. | Finansdirektör/CFO | 2021-08-16 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Företagsledare/Principal | - |
Tidigare kända positioner av James Kelly
| Företag | Position | Slut |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2021-08-13 |
| VANDA PHARMACEUTICALS INC. | Finansdirektör/CFO | 2020-03-15 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Revisor | 2010-12-01 |
| BIOGEN INC. | Företagsledare/Principal | 2005-11-01 |
| AETNA | Företagsledare/Principal | 2000-06-01 |
James Kellys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
79
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Aetna, Inc.
 Aetna, Inc. Managed Health CareHealth Services Provides health insurance plans services | Health Services |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
